Global Rx Market Will Grow 6%-7% In 2004, Roche Predicts
This article was originally published in The Pink Sheet Daily
The company expects its own performance will surpass the market growth rate.
You may also be interested in...
Roche has not seen any change in market dynamics for its products following the switch to an average sales price-based reimbursement model for Medicare Part B drugs
President Biden’s relationship with the US pharmaceutical industry is starting out with the starkest contrast imaginable with the initial approach of the Trump Administration – at least on the symbolic level.